Advanced Biomed Inc. Common Stock (ADVB)

• Market cap: $36.1M
• 1 day: -7.73%
• 5 days: -10.70%
• 1 month: -56.51%
• 3 months: -54.25%
• 6 months: -54.25%
• Year to date: -54.25%
• 1 year: -54.25%
• 5 years: -54.25%
• 10 years: -54.25%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.